Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 4, Open-label Study to Evaluate Treatment Satisfaction With Erenumab in Patients With Migraine

NCT04825678 is registered in ClinicalTrials.gov with Amgen as lead sponsor.

NCT NCT04825678
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04825678 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 4, Open-label Study to Evaluate Treatment Satisfaction With Erenumab in Patients With Migraine
Lead sponsor
Amgen
Phase
Phase 4
Overall status
Completed
Start date
June 11, 2021
Completion date
September 28, 2023
Enrollment
240 (actual)
Sites
42

Conditions

As the registry lists them; a condition with its own page is linked.

migraine